Nykode Therapeutics and Richter-Helm BioLogics Announce Stra

  OSLO, Norway, December 19, 2022 / B3C newswire / -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that it has entered into a strategic manufacturing partnership with Richter-Helm BioLogi...

Related Keywords

Oslo , Norway , Germany , Hamburg , Mette Husbyn , Kai Pohlmeyer , Agnete Fredriksen , Linkedin , Genentech , International Cooperation , Roche Group , Helm Biologics Gmbh Co , Gedeon Richter Plc , Oslo Stock Exchange , Nykode Therapeutics , Richter Helm Biologics Gmbh , Chief Technology Officer , Managing Director , Richter Helm Biologics , Antigen Presenting Cells , Adaptive Biotechnologies , Drug Substance , Industrial Facilities , Biological Products ,